News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
769,408 Results
Type
Article (49122)
Company Profile (502)
Press Release (719766)
Multimedia
Podcasts (134)
Webinars (22)
Section
Business (217724)
Career Advice (2385)
Deals (37159)
Drug Delivery (122)
Drug Development (85510)
Employer Resources (185)
FDA (17172)
Job Trends (15777)
News (366498)
Policy (34405)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2854)
Accelerated approval (34)
Adcomms (29)
Allergies (143)
Alliances (53378)
ALS (176)
Alzheimer's disease (1761)
Antibody-drug conjugate (ADC) (330)
Approvals (17395)
Artificial intelligence (556)
Autoimmune disease (153)
Automation (38)
Bankruptcy (377)
Best Places to Work (12282)
BIOSECURE Act (22)
Biosimilars (197)
Biotechnology (341)
Bladder cancer (163)
Brain cancer (60)
Breast cancer (656)
Cancer (4974)
Cardiovascular disease (430)
Career advice (2013)
Career pathing (40)
CAR-T (293)
CDC (52)
Celiac Disease (2)
Cell therapy (790)
Cervical cancer (36)
Clinical research (72563)
Collaboration (1825)
Company closure (4)
Compensation (1164)
Complete response letters (68)
COVID-19 (2842)
CRISPR (97)
C-suite (881)
Cystic fibrosis (153)
Data (6304)
Decentralized trials (2)
Denatured (42)
Depression (146)
Diabetes (515)
Diagnostics (7071)
Digital health (46)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (264)
Drug pricing (205)
Drug shortages (30)
Duchenne muscular dystrophy (240)
Earnings (93574)
Editorial (64)
Employer branding (22)
Employer resources (162)
Events (126282)
Executive appointments (1029)
FDA (20352)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1542)
Gene editing (213)
Generative AI (48)
Gene therapy (648)
GLP-1 (1061)
Government (4923)
Grass and pollen (6)
Guidances (386)
Healthcare (20222)
HIV (60)
Huntington's disease (47)
IgA nephropathy (86)
Immunology and inflammation (276)
Immuno-oncology (61)
Indications (104)
Infectious disease (3115)
Inflammatory bowel disease (201)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (251)
Interviews (388)
IPO (17236)
IRA (54)
Job creations (3874)
Job search strategy (1686)
JPM (66)
Kidney cancer (15)
Labor market (84)
Layoffs (603)
Leadership (39)
Legal (8300)
Liver cancer (95)
Longevity (15)
Lung cancer (667)
Lymphoma (379)
Machine learning (43)
Management (64)
Manufacturing (817)
MASH (171)
Medical device (14486)
Medtech (14540)
Mergers & acquisitions (21009)
Metabolic disorders (1348)
Multiple sclerosis (161)
NASH (20)
Neurodegenerative disease (339)
Neuropsychiatric disorders (96)
Neuroscience (3055)
Neurotech (1)
NextGen: Class of 2026 (7193)
Non-profit (4890)
Now hiring (65)
Obesity (648)
Opinion (306)
Ovarian cancer (166)
Pain (205)
Pancreatic cancer (231)
Parkinson's disease (297)
Partnered (35)
Patents (499)
Patient recruitment (492)
Peanut (58)
People (63474)
Pharmaceutical (91)
Pharmacy benefit managers (30)
Phase 1 (22798)
Phase 2 (31954)
Phase 3 (23675)
Pipeline (5196)
Policy (312)
Postmarket research (2671)
Preclinical (9808)
Press Release (72)
Prostate cancer (245)
Psychedelics (55)
Radiopharmaceuticals (299)
Rare diseases (903)
Real estate (6418)
Recruiting (73)
Regulatory (25743)
Reports (52)
Research institute (2636)
Resumes & cover letters (392)
Rett syndrome (28)
RNA editing (21)
RSV (77)
Schizophrenia (156)
Series A (259)
Series B (197)
Service/supplier (14)
Sickle cell disease (103)
Special edition (26)
Spinal muscular atrophy (172)
Sponsored (45)
Startups (3917)
State (2)
Stomach cancer (20)
Supply chain (107)
Tariffs (94)
The Weekly (90)
Vaccines (1067)
Venture capital (97)
Weight loss (434)
Women's health (89)
Worklife (20)
Date
Today (8)
Last 7 days (631)
Last 30 days (2314)
Last 365 days (31382)
2026 (2980)
2025 (31798)
2024 (37015)
2023 (41874)
2022 (53245)
2021 (57875)
2020 (56479)
2019 (49662)
2018 (37554)
2017 (34347)
2016 (33959)
2015 (40175)
2014 (33837)
2013 (28950)
2012 (31128)
2011 (31649)
2010 (29690)
Location
Africa (833)
Alabama (91)
Alaska (7)
Arizona (327)
Arkansas (14)
Asia (43099)
Australia (7245)
California (11502)
Canada (3309)
China (1149)
Colorado (484)
Connecticut (497)
Delaware (337)
Europe (96271)
Florida (1687)
Georgia (371)
Hawaii (3)
Idaho (66)
Illinois (913)
India (64)
Indiana (526)
Iowa (24)
Japan (432)
Kansas (130)
Kentucky (43)
Louisiana (27)
Maine (72)
Maryland (1418)
Massachusetts (8411)
Michigan (350)
Minnesota (647)
Mississippi (6)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (126)
New Hampshire (84)
New Jersey (3067)
New Mexico (32)
New York (3040)
North Carolina (1556)
North Dakota (10)
Northern California (5560)
Ohio (349)
Oklahoma (22)
Oregon (47)
Pennsylvania (2304)
Puerto Rico (23)
Rhode Island (48)
South America (1241)
South Carolina (67)
South Dakota (1)
Southern California (4467)
Tennessee (176)
Texas (1801)
United States (41189)
Utah (345)
Vermont (1)
Virginia (275)
Washington D.C. (85)
Washington State (964)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
769,408 Results for "lead therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Press Releases
NK Cell Therapeutics Autologous vs. Allogeneic: Who Will Lead the Race to Commercialization? - Commentary by Unexakorea
February 6, 2026
·
1 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Press Releases
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72
January 6, 2026
·
8 min read
Press Releases
Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204
February 3, 2026
·
1 min read
Press Releases
Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
January 8, 2026
·
7 min read
Press Releases
Transneural Therapeutics Presents Preclinical Data on Lead Candidate TN-001 at 64th Annual Meeting of ACNP (2026)
January 15, 2026
·
3 min read
Press Releases
Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs
January 13, 2026
·
11 min read
Press Releases
Rein Therapeutics Receives Orphan Drug Designation from European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis
January 20, 2026
·
4 min read
Press Releases
TempraMed Signs Exclusive Distribution Agreement with Leading Consumer Health Distributor in Israel
Leading distributor of global companies including GSK/Haleon, Cargill, Reynolds, Paskesz Guri distributes reputable brands including Sensodyne, Aquafresh, Parodontax, Truvia, Diamond and more Strategic agreement supports TempraMed’s global shift from online B2C to major pharmacy networks and B2B medical payers Distribution to over 2,500 outlets including pharmacy chains, supermarkets, HMOs and independent pharmacies
November 26, 2025
·
7 min read
1 of 76,941
Next
